| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e5c121269689cbab9b3a4548b15caf3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fe9efcec7d9ed77f844ba87d886fb92c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3231 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
| filingDate |
2012-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec1f7013eeef1dd64e225b80b2f9bec5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f9a2c76a338497853fd91e1dfaa919a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c40ef7c3ca5e7467e2a3e0eef4bee9f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa8e6a58966b8679366db00f1860514d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ec5f563fd5e701b3b041b12704bff62 |
| publicationDate |
2015-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2015165772-A |
| titleOfInvention |
Oligonucleotide and therapeutic agent for dyslipidemia containing oligonucleotide as an active ingredient |
| abstract |
Provided is an oligonucleotide that exhibits a higher therapeutic effect on dyslipidemia at a lower dose targeting the PCSK9 gene. An oligonucleotide containing a sugar-modified nucleoside, wherein the sugar-modified nucleoside has a cross-linking structure between the 4′-position and the 2′-position, and can bind to a human PCSK9 gene. Is a DNA or RNA consisting of a base sequence containing either a specific base sequence or a base sequence complementary thereto. [Selection figure] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11234995-B2 |
| priorityDate |
2012-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |